HSA
EDIT icon

HBK Sorce Advisory’s Editas Medicine EDIT Stock Holding History

HBK Sorce Advisory’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4,952
Closed -$203K – 608
2021
Q3 		$203K Buy
4,952
+147
+3% +$8.05K 0.01% 555
2021
Q2 		$272K Buy
+4,805
New +$177K 0.02% 471
2018
Q4 		– Sell
-6,382
Closed -$203K – 393
2018
Q3 		$203K Buy
+6,382
New +$206K 0.02% 376

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

HBK Sorce Advisory's EDIT Position: Q4 2021 in Review

HBK Sorce Advisory sold out of Editas Medicine (EDIT) in Q4 2021, closing a stake of 4,952 shares — an estimated $203K sold.

HBK Sorce Advisory first reported a position in EDIT in Q3 2018 and held it in 3 quarters. The position peaked at $272K in Q2 2021. 305 funds tracked by Wall St. Rank hold EDIT as of Q4 2021.

  • HBK Sorce Advisory reported no remaining Editas Medicine position as of Q4 2021 after selling out during the quarter.
  • HBK Sorce Advisory sold 4,952 Editas Medicine shares in Q4 2021, an estimated $203K.
  • HBK Sorce Advisory first reported a position in Editas Medicine in Q3 2018 and held it in 3 quarters.
  • HBK Sorce Advisory's Editas Medicine position peaked at $272K in Q2 2021.
  • 305 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2021.

Based on HBK Sorce Advisory's 13F filing for Q4 2021, filed 15 Feb 2022.